Literature DB >> 2968200

Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.

L G Filion1, R Saginur, N Szczerbak.   

Abstract

The kinetics of the cellular and humoral responses of 30 recipients of hepatitis B vaccine were studied. All individuals exerted an HBsAg blastogenic response sometime throughout the study period but the maximum response was detected on day 28 and 56. The removal of CD8+ cells enhanced significantly the HBsAg response at the times tested, whereas treatment with anti-CD4, anti-CD8, C' and anti-CD4+ C' had no effect. Vaccination also led to the depression of phytohaemagglutinin (PHA) blastogenic response. This response was maximally suppressed 4 to 8 days after immunization at least for the primary and secondary responses and 28 days after the third dose of vaccine. The humoral response to HBsAg was detected only after the second dose of vaccine was given. The results suggest that a CD8+ cell controls the magnitude and intensity of the HBsAg blastogenic response, which may help to explain why several investigators had not been able to detect this response in hyperimmunized individuals. Primary immunization with HBsAg does lead to an expansion of B memory since a secondary response anti-HBsAg was observed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968200      PMCID: PMC1541666     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection.

Authors:  V Barnaba; M Levrero; A D Van Dyke; A Musca; C Cordova; F Balsano
Journal:  Clin Immunol Immunopathol       Date:  1985-03

2.  In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine.

Authors:  T W Chang; E Celis; R W Miller; V R Zurawski; P C Kung
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

3.  Suppressor cell activity in viral and non-viral chronic active hepatitis.

Authors:  F Tremolada; G Fattovich; G Panebianco; G Ongaro; G Realdi
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

Review 4.  The effects of influenza on host defenses.

Authors:  R B Couch
Journal:  J Infect Dis       Date:  1981-09       Impact factor: 5.226

5.  Inducer and suppressor T-cells in hepatitis B virus-induced liver disease.

Authors:  H C Thomas; D Brown; G Routhier; G Janossy; P C Kung; G Goldstein; S Sherlock
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

6.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Abnormalities of immunoregulatory T cells in disorders of immune function.

Authors:  E L Reinherz; A Rubinstein; R S Geha; A J Strelkauskas; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-11-08       Impact factor: 91.245

8.  Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection.

Authors:  V Barnaba; A Musca; C Cordova; M Levrero; G Ruocco; V Albertini-Petroni; F Balsano
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness.

Authors:  F V Chisari; K L Castle; C Xavier; D S Anderson
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

View more
  7 in total

1.  The role of CD4+ lymphocytes in the activation of non-specific suppressor cells by antigen.

Authors:  H Stefanovic; C Izaguirre; L G Filion
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

2.  Induction of the in vitro anti-HBs response by hepatitis B surface antigen.

Authors:  L G Filion; R Saginur
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

3.  Anti-idiotypic antibody production in hepatitis B vaccine recipients.

Authors:  K Kobayashi; Y Ueno; H Suzuki; M Miura; R Nagatomi; M Ishii; T Toyota
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

Review 4.  Sensitization and tolerization to brain antigens in stroke.

Authors:  K J Becker
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

5.  Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination.

Authors:  G Hess; V Hingst; J Cseke; H L Bock; R Clemens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

6.  Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Authors:  Michael L Landrum; Katherine Huppler Hullsiek; Robert J O'Connell; Helen M Chun; Anuradha Ganesan; Jason F Okulicz; Tahaniyat Lalani; Amy C Weintrob; Nancy F Crum-Cianflone; Brian K Agan
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

7.  Improved CD4 T cell profile in HIV-infected subjects on maraviroc-containing therapy is associated with better responsiveness to HBV vaccination.

Authors:  Inés Herrero-Fernández; Isaac Rosado-Sánchez; Miguel Genebat; Laura Tarancón-Díez; María Mar Rodríguez-Méndez; María Mar Pozo-Balado; Carmen Lozano; Ezequiel Ruiz-Mateos; Manuel Leal; Yolanda M Pacheco
Journal:  J Transl Med       Date:  2018-08-29       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.